Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  copanlisib
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 17067, NCI-2015-01865, 2013-003893-29, NCT02367040
Copanlisib, Letrozole, and Palbociclib in Treating Patients with Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer
Status: Not yet active
Phase: Phase II, Phase I
Type: Treatment
Age: 19 and over
Trial IDs: 16-001271, NCI-2017-00435, NCT03128619
Copanlisib in Treating Patients with Persistent or Recurrent Endometrial Cancer
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NRG-GY008, NCI-2016-00325, NRG-DT1419, NCT02728258
Copanlisib, Gemcitabine, and Cisplatin in Treating Patients with Advanced Cholangiocarcinoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC-18435, NCI-2016-01029, NCT02631590
Start Over